Last year, Zoetis Inc generated 2.34B USD for its biggest-performing segment, Parasiticides. The United States made the largest contribution, accounting for 5.10B USD last year. For the latest quarter, Zoetis Inc reported the revenue of 698.00M USD for the period ending 2026-06-30, which came from the top-performing segment, Parasiticides. United States contributed the highest revenue, at 1.27B USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Parasiticides

Vaccines

Dermatology

Anti-infectives

Pain and sedation

Other pharmaceuticals

Animal health diagnostics

Other non-pharmaceuticals

Contact manufacturing and human health daignostics

Medicated feed additives

Pain and sedation

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Parasiticides

2.34B(24.73%)

2.15B(23.26%)

1.95B(22.79%)

1.86B(23.02%)

1.64B(21.03%)

1.17B(17.57%)

966.00M(15.43%)

836.00M(14.35%)

Vaccines

1.96B(20.69%)

1.83B(19.74%)

1.77B(20.73%)

1.72B(21.26%)

1.67B(21.51%)

1.48B(22.11%)

1.48B(23.69%)

1.49B(25.55%)

Dermatology

1.75B(18.53%)

1.66B(17.88%)

1.43B(16.70%)

1.33B(16.45%)

1.18B(15.17%)

941.00M(14.10%)

770.00M(12.30%)

--(--)

Anti-infectives

1.04B(10.94%)

1.10B(11.88%)

1.06B(12.37%)

1.08B(13.38%)

1.22B(15.63%)

1.21B(18.07%)

1.25B(20.03%)

1.28B(21.97%)

Pain and sedation

840.00M(8.87%)

--(--)

Other pharmaceuticals

697.00M(7.36%)

658.00M(7.11%)

1.28B(14.98%)

1.04B(12.91%)

966.00M(12.42%)

821.00M(12.30%)

780.00M(12.46%)

1.37B(23.55%)

Animal health diagnostics

434.00M(4.58%)

386.00M(4.17%)

376.00M(4.40%)

353.00M(4.37%)

374.00M(4.81%)

305.00M(4.57%)

268.00M(4.28%)

136.00M(2.33%)

Other non-pharmaceuticals

263.00M(2.78%)

253.00M(2.73%)

254.00M(2.97%)

250.00M(3.09%)

231.00M(2.97%)

210.00M(3.15%)

184.00M(2.94%)

170.00M(2.92%)

Contact manufacturing and human health daignostics

116.00M(1.23%)

80.00M(0.86%)

78.00M(0.91%)

86.00M(1.06%)

82.00M(1.05%)

83.00M(1.24%)

85.00M(1.36%)

58.00M(1.00%)

Medicated feed additives

27.00M(0.29%)

293.00M(3.17%)

354.00M(4.14%)

360.00M(4.46%)

420.00M(5.40%)

460.00M(6.89%)

470.00M(7.51%)

485.00M(8.33%)

Pain and sedation

--(--)

851.00M(9.19%)

--(--)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

United States

Other emerging markets

Other Developed

Brazil

Australia

United Kingdom

Canada

Germany

China

France

Mexico

Japan

Spain

Chile

Italy

Contract Manufacturing

International

Unallocated

Europe/Africa/Middle East (EuAfME)

Canada/Latin America (CLAR)

Asia/Pacific (APAC)

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

United States

5.10B(53.84%)

5.07B(54.82%)

4.55B(53.31%)

4.31B(53.38%)

4.04B(51.98%)

3.56B(53.29%)

3.20B(51.17%)

2.88B(49.39%)

2.62B(49.37%)

2.45B(50.06%)

2.33B(48.86%)

2.06B(43.03%)

1.90B(41.70%)

1.78B(40.96%)

1.66B(39.19%)

Other emerging markets

913.00M(9.64%)

865.00M(9.35%)

784.00M(9.18%)

758.00M(9.38%)

778.00M(10.01%)

656.00M(9.83%)

--(--)

Other Developed

641.00M(6.77%)

564.00M(6.09%)

512.00M(5.99%)

468.00M(5.79%)

467.00M(6.01%)

388.00M(5.81%)

--(--)

Brazil

393.00M(4.15%)

414.00M(4.47%)

393.00M(4.60%)

330.00M(4.08%)

312.00M(4.01%)

258.00M(3.87%)

--(--)

Australia

329.00M(3.48%)

319.00M(3.45%)

323.00M(3.78%)

289.00M(3.58%)

259.00M(3.33%)

207.00M(3.10%)

--(--)

United Kingdom

325.00M(3.43%)

314.00M(3.39%)

277.00M(3.24%)

235.00M(2.91%)

234.00M(3.01%)

178.00M(2.67%)

--(--)

Canada

290.00M(3.06%)

277.00M(2.99%)

255.00M(2.98%)

238.00M(2.95%)

232.00M(2.98%)

210.00M(3.15%)

--(--)

Germany

236.00M(2.49%)

225.00M(2.43%)

202.00M(2.36%)

176.00M(2.18%)

183.00M(2.35%)

159.00M(2.38%)

--(--)

China

227.00M(2.40%)

270.00M(2.92%)

320.00M(3.75%)

382.00M(4.73%)

357.00M(4.59%)

266.00M(3.99%)

--(--)

France

165.00M(1.74%)

156.00M(1.69%)

142.00M(1.66%)

126.00M(1.56%)

132.00M(1.70%)

118.00M(1.77%)

--(--)

Mexico

160.00M(1.69%)

169.00M(1.83%)

162.00M(1.90%)

136.00M(1.68%)

133.00M(1.71%)

116.00M(1.74%)

--(--)

Japan

154.00M(1.63%)

147.00M(1.59%)

158.00M(1.85%)

173.00M(2.14%)

186.00M(2.39%)

177.00M(2.65%)

--(--)

Spain

145.00M(1.53%)

130.00M(1.40%)

122.00M(1.43%)

118.00M(1.46%)

128.00M(1.65%)

112.00M(1.68%)

--(--)

Chile

139.00M(1.47%)

123.00M(1.33%)

140.00M(1.64%)

141.00M(1.75%)

136.00M(1.75%)

100.00M(1.50%)

--(--)

Italy

137.00M(1.45%)

129.00M(1.39%)

121.00M(1.42%)

111.00M(1.37%)

115.00M(1.48%)

90.00M(1.35%)

--(--)

Contract Manufacturing

116.00M(1.23%)

80.00M(0.86%)

78.00M(0.91%)

86.00M(1.06%)

82.00M(1.05%)

83.00M(1.24%)

85.00M(1.36%)

58.00M(1.00%)

44.00M(0.83%)

51.00M(1.04%)

--(--)

International

--(--)

2.97B(47.48%)

2.89B(49.61%)

2.64B(49.80%)

2.39B(48.90%)

2.39B(50.07%)

--(--)

Unallocated

--(--)

51.00M(1.07%)

50.00M(1.04%)

53.00M(1.16%)

28.00M(0.65%)

--(--)

Europe/Africa/Middle East (EuAfME)

--(--)

1.14B(23.85%)

1.11B(24.45%)

1.07B(24.63%)

1.14B(27.03%)

Canada/Latin America (CLAR)

--(--)

815.00M(17.03%)

778.00M(17.06%)

769.00M(17.74%)

788.00M(18.62%)

Asia/Pacific (APAC)

--(--)

720.00M(15.05%)

713.00M(15.63%)

695.00M(16.03%)

642.00M(15.17%)